(Q34727136)

4 August 2017

1 reference

title

Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation (English)

1 reference

Hormone Replacement Therapy

4 August 2017

main subject

1 reference

1 reference

1

Mary Cushman

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

90

1 reference

4 August 2017

issue

1A

1 reference

4 August 2017

page(s)

7F-10F

1 reference

Hormones to prevent coronary disease in women: when are observational studies adequate evidence?

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Design and methods of the Raloxifene Use for The Heart (RUTH) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Hormone replacement therapy, inflammation, and hemostasis in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Direct proinflammatory effect of C-reactive protein on human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902419-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02419-0

1 reference

4 August 2017

1 reference